Lhasa Limited shared knowledge shared progress

Developing structure-activity relationships for N-nitrosamine activity

Cross K; Ponting DJ;

In this paper, Dr. Kevin Cross from Instem and Lhasa Principal Scientist, Dr. David Ponting investigate whether improvements in SARs can more accurately predict N-nitrosamine carcinogenic potency.

A working group of 23 companies and universities was established with the goals of addressing several scientific and regulatory issues and improved methods for calculating acceptable intake limits for N-nitrosamines based upon mechanistic analogs. Kevin & David describe this collaboration and review their current progress towards development of mechanistically based structure–activity relationships.

You can read this open access publication via this link.


If you're interested in complex nitrosamines, you may enjoy Lhasa Principal Application Scientist, Fernanda Waechter's video below which mentions this publication.




Visit site

Related Publications

© 2022 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.